title: Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia.
authors.affiliation: University College London, Cancer Institute, London WC1E 6BT, UK.
authors.forename: Christoph
authors.initials: C
authors.lastname: Lutz
authors.affiliation: MRC MHU, WIMM, University of Oxford, Oxford OX3 9DS, UK.|HSCB, WIMM, University of Oxford, Oxford OX3 9DS, UK.
authors.forename: Petter S
authors.initials: PS
authors.lastname: Woll
authors.affiliation: Department of Paediatric Haematology/Oncology, Oxford Radcliffe Hospitals NHS Trust, Oxford OX3 9DU, UK.
authors.forename: Georgina
authors.initials: G
authors.lastname: Hall
authors.affiliation: Department of Paediatric Haematology, Lund University Hospital, Sweden.
authors.forename: Anders
authors.initials: A
authors.lastname: Castor
authors.affiliation: Department of Haematology, Oxford Radcliffe Hospitals NHS Trust, Oxford OX3 9DU, UK.
authors.forename: Helene
authors.initials: H
authors.lastname: Dreau
authors.affiliation: Centro Ricerca Tettamanti, Clinica Pediatrica Univ. Milano Bicocca, Ospedale San Gerardo, Monza, Italy.
authors.forename: Giovanni
authors.initials: G
authors.lastname: Cazzaniga
authors.affiliation: Second Medical School Dept. of Paediatric Hem./Onc., Charles Univ., Prague, Prague, Czech Republic.
authors.forename: Jan
authors.initials: J
authors.lastname: Zuna
authors.affiliation: University College London, Cancer Institute, London WC1E 6BT, UK.
authors.forename: Christina
authors.initials: C
authors.lastname: Jensen
authors.affiliation: MRC MHU, WIMM, University of Oxford, Oxford OX3 9DS, UK.|HSCB, WIMM, University of Oxford, Oxford OX3 9DS, UK.
authors.forename: Sally A
authors.initials: SA
authors.lastname: Clark
authors.affiliation: Centro Ricerca Tettamanti, Clinica Pediatrica Univ. Milano Bicocca, Ospedale San Gerardo, Monza, Italy.
authors.forename: Andrea
authors.initials: A
authors.lastname: Biondi
authors.affiliation: Department of Paediatric Haematology/Oncology, Oxford Radcliffe Hospitals NHS Trust, Oxford OX3 9DU, UK.
authors.forename: Chris
authors.initials: C
authors.lastname: Mitchell
authors.affiliation: MRC MHU, WIMM, University of Oxford, Oxford OX3 9DS, UK.|HSCB, WIMM, University of Oxford, Oxford OX3 9DS, UK.
authors.forename: Helen
authors.initials: H
authors.lastname: Ferry
authors.affiliation: Department of Haematology, Oxford Radcliffe Hospitals NHS Trust, Oxford OX3 9DU, UK.
authors.forename: Anna
authors.initials: A
authors.lastname: Schuh
authors.affiliation: MRC MHU, WIMM, University of Oxford, Oxford OX3 9DS, UK.
authors.forename: Veronica
authors.initials: V
authors.lastname: Buckle
authors.affiliation: MRC MHU, WIMM, University of Oxford, Oxford OX3 9DS, UK.|HSCB, WIMM, University of Oxford, Oxford OX3 9DS, UK.
authors.forename: Sten-Eirik W
authors.initials: SW
authors.lastname: Jacobsen
authors.affiliation: University College London, Cancer Institute, London WC1E 6BT, UK.
authors.forename: Tariq
authors.initials: T
authors.lastname: Enver
mesh_terms: D002453:Cell Cycle / Q000187:drug effects; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D018365:Neoplasm, Residual; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000473:pathology*